Cargando…
AMBITION: An important piece in the therapeutic puzzle of pulmonary arterial hypertension
It is believed that simultaneous targeting of two or more of the three pathogenic pathways of pulmonary arterial hypertension (the endothelin, nitric oxide, and prostacyclin pathways) is associated with additive or synergistic effects with subsequent increasing efficacy and improving outcomes. Howev...
Autor principal: | Said, Karim |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bloomsbury Qatar Foundation Journals
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4710867/ https://www.ncbi.nlm.nih.gov/pubmed/26779523 http://dx.doi.org/10.5339/gcsp.2015.48 |
Ejemplares similares
-
Macitentan in pulmonary arterial hypertension: The SERAPHIN trial
por: Said, Karim
Publicado: (2014) -
Anticoagulation in pulmonary arterial hypertension: Contemporary data from COMPERA registry
por: Said, Karim
Publicado: (2014) -
Hokusai-VTE: Edoxaban for the treatment of venous thromboembolism
por: Said, Karim
Publicado: (2013) -
Riociguat: PATENT-1 Study
por: Said, Karim
Publicado: (2014) -
DECAAF: Emphasizing the importance of MRI in AF ablation
por: ElMaghawry, Mohamed, et al.
Publicado: (2015)